U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07162675) titled 'Step Count and Treatment Response in Neoadjuvant Breast Cancer' on Aug. 24.
Brief Summary: This prospective multicenter observational study (NEOBRE-STEP) investigates the impact of daily step counts, measured by Huawei Fit 2 smartwatches, on treatment response in patients with non-metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-negative breast cancer undergoing neoadjuvant systemic therapy. Patients will wear smartwatches to continuously record step counts, activity intensity, sleep, and heart rate. Patient-reported outcomes, including sleep quality (Pittsburgh Sleep Quality Index, PSQI) and quality of life (European Org...